ArticleFrontiers in immunology2022

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials.

Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.